• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Sara Tolaney, MD, MPH

Publications

  • Tolaney SM, Jeong J, Guo H, Brock J, Morganstern D, Come SE, Golshan M, Bellon J, Winer EP, Krop IE.A phase II study of preoperative capecitabine in women with operable hormone receptor positive breast cancer.Cancer Med. 2014 Apr;3(2):293-9.
    24464780
  • Tolaney S.New HER2-positive targeting agents in clinical practice.Curr Oncol Rep. 2014 Jan;16(1):359.
    24442625
  • Proia DA, Zhang C, Sequeira M, Jimenez JP, He S, Spector N, Shapiro GI, Tolaney S, Nagai M, Acquaviva J, Smith DL, Sang J, Bates RC, El-Hariry I.Preclinical activity profile and therapeutic efficacy of the HSP90 inhibitor ganetespib in triple-negative breast cancer.Clin Cancer Res. 2014 Jan 15;20(2):413-24.
    24173541
  • Gandhi L, Bahleda R, Tolaney SM, Kwak EL, Cleary JM, Pandya SS, Hollebecque A, Abbas R, Ananthakrishnan R, Berkenblit A, Krygowski M, Liang Y, Turnbull KW, Shapiro GI, Soria JC.Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors.J Clin Oncol. 2014 Jan 10;32(2):68-75.
    24323026
  • Ruddy KJ, Desantis SD, Gelman RS, Wu AH, Punglia RS, Mayer EL, Tolaney SM, Winer EP, Partridge AH, Burstein HJ.Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice.Breast Cancer Res Treat. 2013 Oct;141(3):421-7.
    24062210
  • Gucalp A, Tolaney S, Isakoff SJ, Ingle JN, Liu MC, Carey LA, Blackwell K, Rugo H, Nabell L, Forero A, Stearns V, Doane AS, Danso M, Moynahan ME, Momen LF, Gonzalez JM, Akhtar A, Giri DD, Patil S, Feigin KN, Hudis CA, Traina TA, .Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer.Clin Cancer Res. 2013 Oct 1;19(19):5505-12.
    23965901
  • Kansal KJ, Dominici LS, Tolaney SM, Isakoff SJ, Smith BL, Jiang W, Brock JE, Winer EP, Krop IE, Golshan M.Neoadjuvant bevacizumab: surgical complications of mastectomy with and without reconstruction.Breast Cancer Res Treat. 2013 Sep;141(2):255-9.
    24026859
  • Liu JF, Tolaney SM, Birrer M, Fleming GF, Buss MK, Dahlberg SE, Lee H, Whalen C, Tyburski K, Winer E, Ivy P, Matulonis UA.A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer.Eur J Cancer. 2013 Sep;49(14):2972-8.
    23810467
  • Garber JE, Halabi S, Tolaney SM, Kaplan E, Archer L, Atkins JN, Edge S, Shapiro CL, Dressler L, Paskett ED, Paskett EM, Kimmick G, Orcutt J, Scalzo A, Winer E, Levine E, Shahab N, Berliner N, .Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer.Journal of the National Cancer Institute. 2010 Jul 7;102(13):942-9.
    20554945
  • Tolaney SM,Krop IE.Mechanisms of trastuzumab resistance in breast cancer.Anticancer Agents Med Chem. 2009 Mar;9(3):348-55. Review.
    19275526
  • Tolaney SM,Najita J,Winer EP,Burstein HJ.Lymphopenia associated with adjuvant anthracycline/ taxane regimens.Clin Breast Cancer. 2008 Aug;8(4):352-6.
    18757263
  • Tolaney SM, Colson YL, Gill RR, Schulte S, Duggan MM, Shulman LN, Winer EP.Sarcoidosis mimicking metastatic breast cancer.Clin Breast Cancer. 2007 Oct;7(10):804-10.
    18021484
  • Tolaney SM,Winer EP.Follow-up care of patients with breast cancer.Breast. 2007 Dec;16 Suppl 2:S45-50.
    17697780
  • Tolaney SM, Partridge AH, Sheib RG, Burstein HJ, Winer EP.Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer.J Clin Oncol. 2006 Nov 20;24(33):5330-1.
    17114668